|
Britain's Medicines Control
Agency (MCA) proposed on July 14 to follow Germany and ban the supply
of the herbal remedy kava-kava after reports linking it to fatal liver
failure.
Suppliers voluntarily withdrew
the remedy, which is most often marketed as a sedative, muscle relaxant
and diuretic, from the UK market last year while experts investigated
its safety.
The MCA said it was now aware
of 68 cases worldwide of liver problems suspected to be associated with
the ingredient, which is derived from peppers native to the South Pacific
islands.
"These include cases of
liver failure resulting in six liver transplants and three deaths,"
it added in a statement.
Professor Alasdair Breckenridge,
chairman of the Committee on Safety of Medicines, said: "Our advice
is that it would be prudent for anyone taking such products to stop taking
them.
"There should not be any
adverse effects from stopping kava-kava abruptly. If anyone taking kava-kava
feels unwell or has concerns about possible liver problems they should
stop taking the kava-kava and seek medical advice."
The MCA said consultation on
its proposal to prohibit the supply of kava-kava products would last until
27 September 2002. Germany announced a ban last month.
The World Health Organization
announced earlier this year it aims to set up a global framework within
4 years to monitor the safety of traditional and alternative medicines
following a number of deaths linked to their use.
British
Broadcast Corporation July 18, 2002
|